{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:35:52Z","timestamp":1773236152069,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":7525,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.1038\/ki.1995.198","type":"journal-article","created":{"date-parts":[[2007,5,21]],"date-time":"2007-05-21T17:49:33Z","timestamp":1179769773000},"page":"1412-1418","source":"Crossref","is-referenced-by-count":87,"title":["Efficacy and tolerance of \u03b1-2b interferon therapy on HCV infection of hemodialyzed patients"],"prefix":"10.1016","volume":"47","author":[{"given":"Stanislas","family":"Pol","sequence":"first","affiliation":[]},{"given":"Val\u00e9rie","family":"Thiers","sequence":"additional","affiliation":[]},{"given":"Fran\u00e7oise","family":"Carnot","sequence":"additional","affiliation":[]},{"given":"Brigitte","family":"Zins","sequence":"additional","affiliation":[]},{"given":"Raffaella","family":"Romeo","sequence":"additional","affiliation":[]},{"given":"Pierre","family":"Berthelot","sequence":"additional","affiliation":[]},{"given":"Christian","family":"Br\u00e9chot","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1038\/ki.1995.198_bb0010","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archinte.1993.00410030014003","article-title":"Erythropoietin: Biology and clinical applications","volume":"153","author":"Tabbara","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1038\/ki.1995.198_bb0015","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(81)92679-9","article-title":"Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients","volume":"ii","author":"Crosnier","year":"1981","journal-title":"Lancet"},{"key":"10.1038\/ki.1995.198_bb0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM198408233110803","article-title":"Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy","volume":"311","author":"Stevens","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1995.198_bb0025","first-page":"375","article-title":"Liver diseases and hepatic complications in renal transplant patients","volume":"17","author":"Debure","year":"1988","journal-title":"Adv Nephrol"},{"key":"10.1038\/ki.1995.198_bb0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198104233041701","article-title":"Serum alanine amino-transferase of donors in relation to the risk of non-A non-B hepatitis in recipients; the transfusion transmitted virus study","volume":"304","author":"Aach","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1995.198_bb0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulatory antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo","year":"1989","journal-title":"Science"},{"key":"10.1038\/ki.1995.198_bb0040","first-page":"795","article-title":"Outbreak of non-A, non-B hepatitis in centre haemodialysis patients: A retrospective analysis","volume":"3","author":"Marchesi","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.1995.198_bb0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(79)91723-9","article-title":"Non-B hepatitis associated with chronic liver disease in a haemodialyis unit","volume":"1","author":"Galbraith","year":"1979","journal-title":"Lancet"},{"key":"10.1038\/ki.1995.198_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000166815","article-title":"Non-A, non-B hepatitis and chronic dialysis\u2014Another dilemna","volume":"4","author":"Seaworth","year":"1984","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.1995.198_bb0055","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7326\/0003-4819-112-12-958","article-title":"The prevalence of hepatitis C virus antibodies among hemodialysis patients","volume":"112","author":"Zeldis","year":"1990","journal-title":"Ann Int Med"},{"key":"10.1038\/ki.1995.198_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep.1840170103","article-title":"Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays","volume":"17","author":"Chan","year":"1993","journal-title":"Hepatology"},{"key":"10.1038\/ki.1995.198_bb0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0168-8278(05)80318-6","article-title":"Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients","volume":"21","author":"Verdon","year":"1994","journal-title":"J Hepatol"},{"key":"10.1038\/ki.1995.198_bb0070","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.1992.160","article-title":"Risk factors for dialysis-associated hepatitis C in Venezuela","volume":"42","author":"Muller","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.198_bb0075","first-page":"294","article-title":"Antibodies to hepatitis C virus in French blood donors","volume":"2","author":"Janot","year":"1989","journal-title":"Lancet"},{"key":"10.1038\/ki.1995.198_bb0080","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ki.1993.354","article-title":"Hepatitis C virus (HCV) RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications","volume":"44","author":"Pol","year":"1993","journal-title":"Kidney Intern"},{"key":"10.1038\/ki.1995.198_bb0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1600-0676.1983.tb00891.x","article-title":"Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis","volume":"3","author":"Degott","year":"1983","journal-title":"Liver"},{"key":"10.1038\/ki.1995.198_bb0090","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ki.1993.385","article-title":"Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study","volume":"44","author":"Jadoul","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.1995.198_bb0095","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/0140-6736(90)90477-M","article-title":"Chronic hepatitis in kidney allograft recipients","volume":"335","author":"Pol","year":"1990","journal-title":"Lancet"},{"key":"10.1038\/ki.1995.198_bb0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(84)92327-4","article-title":"Recombinant leucocyte interferon alpha induces steroid-resistant acute vascular rejection episodes in renal transplant recipients","volume":"i","author":"Kramer","year":"1984","journal-title":"Lancet"},{"key":"10.1038\/ki.1995.198_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00007890-199409150-00018","article-title":"Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients: A pilot study","volume":"58","author":"Thervet","year":"1994","journal-title":"Transplantation"},{"key":"10.1038\/ki.1995.198_bb0110","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","article-title":"Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized controlled trial","volume":"321","author":"Davis","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1995.198_bb0115","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198911303212204","article-title":"Recombinant interferon alpha therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial","volume":"321","author":"Di Bisceglie","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1995.198_bb0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.1840190203","article-title":"Hepatitis C viremia in chronic liver disease: Relationship to interferon alpha or corticosteroid treatment","volume":"19","author":"Magrin","year":"1994","journal-title":"Hepatology"},{"key":"10.1038\/ki.1995.198_bb0125","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/hep.1840180603","article-title":"Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-\u03b12b","volume":"18","author":"Saracco","year":"1993","journal-title":"Hepatology"},{"key":"10.1038\/ki.1995.198_bb0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.7326\/0003-4819-121-4-199408150-00008","article-title":"Eradication of HCV RNA after alpha-interferon therapy","volume":"121","author":"Rom\u00e9o","year":"1994","journal-title":"Ann Int Med"},{"key":"10.1038\/ki.1995.198_bb0135","first-page":"156","article-title":"Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction","volume":"1962","author":"Chomezynski","year":"1987","journal-title":"Ann Biochem"},{"key":"10.1038\/ki.1995.198_bb0140","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI115723","article-title":"Reinfection of liver graft by hepatitis C virus (HCV) after liver transplantation","volume":"89","author":"F\u00e9ray","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.1995.198_bb0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/339237a0","article-title":"Avoiding false positive results with PCR","volume":"339","author":"Kwok","year":"1989","journal-title":"Nature"},{"key":"10.1038\/ki.1995.198_bb0150","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1099\/0022-1317-74-6-1093","article-title":"Typing of HCV isolates and characterisation of new subtypes using a probe assay","volume":"74","author":"Stuyver","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1038\/ki.1995.198_bb0155","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.1840190538","article-title":"A proposed system for the nomenclature of hepatitis C viral genotype","volume":"19","author":"Simmonds","year":"1994","journal-title":"Hepatology"},{"key":"10.1038\/ki.1995.198_bb0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of numerical scoring systems for assessing histological activity in asymptomatic chronic active hepatitis","volume":"5","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"10.1038\/ki.1995.198_bb0165","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0016-5085(94)90703-X","article-title":"Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with Non-A, Non-B, C hepatitis","volume":"106","author":"Jou\u00ebt","year":"1994","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1038\/ki.1995.198_bb0170","first-page":"S10","article-title":"Which hepatitis C patient will benefit from Interferon? Multivariate analysis of 350 patients treated in a Benelux multicentre study","volume":"18","author":"Brouwer","year":"1993","journal-title":"J Hepatol"},{"key":"10.1038\/ki.1995.198_bb0175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-122-3-199502010-00001","article-title":"Hepatitis C virus type 1b (II) infection in France and Italy","volume":"122","author":"Nousbaum","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.1995.198_bb0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM199401133300215","article-title":"The Hepatitis C serotype and response to interferon therapy","volume":"330","author":"Chemello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1995.198_bb0185","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0006-291X(90)90494-8","article-title":"There are two major types of hepatitis C virus in Japan","volume":"170","author":"Enomoto","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.1995.198_bb0190","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0042-6822(92)90762-E","article-title":"Full-length sequence of hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes","volume":"188","author":"Okamoto","year":"1992","journal-title":"Virology"},{"key":"10.1038\/ki.1995.198_bb0195","doi-asserted-by":"crossref","first-page":"59A","DOI":"10.1016\/0270-9139(93)91763-I","article-title":"HCV type II has a more pathogenic course after liver transplantation","volume":"18","author":"F\u00e9ray","year":"1993","journal-title":"Hepatology"},{"key":"10.1038\/ki.1995.198_bb0200","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0016-5085(95)90088-8","article-title":"The changing prevalence of hepatitis C virus genotypes: Evidence in hemodialyzed patients and kidney recipients","volume":"108","author":"Pol","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1038\/ki.1995.198_bb0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hep.1840160203","article-title":"Detection of hepatitis C virus by polymerase chain reaction and response to Interferon-alpha therapy: Relationship to genotypes of hepatitis C virus","volume":"16","author":"Yoshioka","year":"1992","journal-title":"Hepatology"},{"key":"10.1038\/ki.1995.198_bb0210","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.1995.198_bb0215","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.1840190204","article-title":"High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with Interferon-\u03b12b for 60 weeks","volume":"19","author":"Reichard","year":"1994","journal-title":"Hepatology"},{"key":"10.1038\/ki.1995.198_bb0220","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/0140-6736(91)91707-2","article-title":"Ribavirin treatment for chronic hepatitis C","volume":"337","author":"Reichard","year":"1991","journal-title":"Lancet"},{"key":"10.1038\/ki.1995.198_bb0225","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(05)80550-1","article-title":"Ribavirin treatment of chronic hepatitis C unresponsive to alfa interferon","volume":"19","author":"Camps","year":"1993","journal-title":"J Hepatol"},{"key":"10.1038\/ki.1995.198_bb0230","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(92)92234-7","article-title":"Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV","volume":"340","author":"Alberti","year":"1992","journal-title":"Lancet"},{"key":"10.1038\/ki.1995.198_bb0235","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0140-6736(93)90635-T","article-title":"Significance of serum hepatitis C virus RNA levels in chronic hepatitis C","volume":"341","author":"Lau","year":"1993","journal-title":"Lancet"},{"key":"10.1038\/ki.1995.198_bb0240","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/hep.1840190604","article-title":"Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon","volume":"19","author":"Castillo","year":"1994","journal-title":"Hepatology"},{"key":"10.1038\/ki.1995.198_bb0245","unstructured":"R. Romeo S. Pol C. Demeret V. Thiers D. Kremsdorf E. Cuillerier P. Berthelot C. Br\u00e9chot Evidence of non-A, non-B, non-C infection in chronic hepatitis by polymerase chain reaction testing for hepatitis B and C viruses J Hepatol (in press)"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381558962X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381558962X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T22:58:46Z","timestamp":1635548326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381558962X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["S008525381558962X"],"URL":"https:\/\/doi.org\/10.1038\/ki.1995.198","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}